Worldwide Industry for Microbial Contract Biomanufacturing to 2030 - COVID-19 is Likely to Create Significant Business Opportunities
Share this article Share this article ResearchAndMarkets.com's offering. The report features an extensive study of the current market landscape and future opportunities associated with the microbial contract biomanufacturing market. The study also features a detailed analysis of key drivers and trends related to this evolving domain. Traditionally, microbial cell cultures have been the preferred choice for the production of the variety of biologics, including peptide therapeutics and certain low molecular weight proteins (insulin) and cytokines. Till date, over 60% of recombinant proteins us...
Source: prnewswire.com